Xponance’s Pediatrix Medical MD Stock Holding History

Xponance’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,066	Closed	-$180K	–	1053
2020 Q3	$180K	Sell	11,066 -398	-3%	-$7.4K	﹤0.01%	991
2020 Q2	$196K	Buy	+11,464	New	+$170K	0.01%	975

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Xponance's MD Position: Q4 2020 in Review

Xponance sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 11,066 shares — an estimated $180K sold.

Xponance first reported a position in MD in Q2 2020 and held it in 2 quarters. The position peaked at $196K in Q2 2020. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

Xponance reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
Xponance sold 11,066 Pediatrix Medical shares in Q4 2020, an estimated $180K.
Xponance first reported a position in Pediatrix Medical in Q2 2020 and held it in 2 quarters.
Xponance's Pediatrix Medical position peaked at $196K in Q2 2020.
201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Xponance's 13F filing for Q4 2020, filed 11 Feb 2021.